Correction to “Design, Synthesis, and Structure–Activity Relationship of a Novel Series of GluN2C-Selective Potentiators”

Page 2341. Compound 162 in Table 4 has been misrepresented as having a methyl group in the R₁ position when there should be an isonicotinoyl group.

Page 2345. Compounds 159 and 160 in Table 8 should be drawn as having a methyl group in the 2-postion of the indole and the R¹ should be a methyl group instead of the nicotinoyl group as shown.

Pages 2344–2355. In the section “Chemistry Experimentals”, the above-mentioned compounds do have the correct names and characterization. After rechecking the purity of all of the reported compounds, it was found that compounds 66, 67, 68, 85, 89, 90, 100, and 112 did not meet the J. Med. Chem. purity standards.

Funding Statement

National Institutes of Health, United States